Consistent with its tumor suppressor function, downregulation of DCC expression has been demonstrated in a number of cancer types including colorectal [14], ovarian, pancreatic, hepatocellular carcinomas [15], and neuroblastoma [16]. The gene discussed is DCC; the disease is neoplasm.